• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对有移植相关胃肠道血栓性微血管病证据的造血干细胞移植患者进行胃肠道活检的完整组织学方法。

A Complete Histologic Approach to Gastrointestinal Biopsy From Hematopoietic Stem Cell Transplant Patients With Evidence of Transplant-Associated Gastrointestinal Thrombotic Microangiopathy.

作者信息

Warren Mikako, Jodele Sonata, Dandoy Christopher, Myers Kasiani C, Wallace Gregory, Nelson Adam, El-Bietar Javier

机构信息

From the Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, California (Dr Warren); and the Division of Bone Marrow Transplant and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio (Drs Jodele, Dandoy, Myers, Wallace, Nelson, and El-Bietar).

出版信息

Arch Pathol Lab Med. 2017 Nov;141(11):1558-1566. doi: 10.5858/arpa.2016-0599-RA. Epub 2017 Aug 10.

DOI:10.5858/arpa.2016-0599-RA
PMID:28795840
Abstract

CONTEXT

  • Transplant-associated thrombotic microangiopathy is a serious complication of hematopoietic stem cell transplant that may progress to multi-organ dysfunction. Transplant-associated thrombotic microangiopathy may involve the intestinal vasculature (intestinal transplant-associated thrombotic microangiopathy [iTMA]), causing patients to experience debilitating symptoms of ischemic colitis, including disproportionately severe abdominal pain and gastrointestinal bleeding, requiring heavy narcotic use and frequent transfusion support. Pathophysiology remains poorly investigated but may include endothelial damage mediated by inflammatory markers and the complement system. Endoscopy of hematopoietic stem cell transplant patients often produces biopsy samples, in which mucosal lamina propria capillaries are sufficient for an evaluation of iTMA features.

OBJECTIVE

  • To provide a detailed review of histologic features of iTMA.

DATA SOURCES

  • We conducted a systematic review of studies assessing histologic features of iTMA. Studies were identified by PubMed search and included a cohort study performed by our group.

CONCLUSIONS

  • The histologic hallmark of iTMA is endothelial cell injury that leads to hemorrhage and thrombosis of the capillaries. Histologic features include endothelial cell swelling, endothelial cell separation, perivascular mucosal hemorrhage, intraluminal schistocytes, intraluminal fibrin, intraluminal microthrombi, loss of glands, and total denudation of mucosa. Identification of features consistent with iTMA has immediate implications for clinical management that could potentially improve outcome and survival.
摘要

背景

移植相关血栓性微血管病是造血干细胞移植的一种严重并发症,可进展为多器官功能障碍。移植相关血栓性微血管病可能累及肠道血管(肠道移植相关血栓性微血管病[iTMA]),导致患者出现缺血性结肠炎的衰弱症状,包括不成比例的严重腹痛和胃肠道出血,需要大量使用麻醉剂和频繁输血支持。其病理生理学研究仍较少,但可能包括炎症标志物和补体系统介导的内皮损伤。造血干细胞移植患者的内镜检查常可获取活检样本,其中黏膜固有层毛细血管足以评估iTMA特征。

目的

对iTMA的组织学特征进行详细综述。

数据来源

我们对评估iTMA组织学特征的研究进行了系统综述。通过PubMed搜索确定研究,其中包括我们团队进行的一项队列研究。

结论

iTMA的组织学标志是内皮细胞损伤,导致毛细血管出血和血栓形成。组织学特征包括内皮细胞肿胀、内皮细胞分离、血管周围黏膜出血、管腔内裂体细胞、管腔内纤维蛋白、管腔内微血栓、腺体缺失和黏膜完全剥脱。识别与iTMA一致的特征对临床管理具有直接意义,可能改善预后和生存率。

相似文献

1
A Complete Histologic Approach to Gastrointestinal Biopsy From Hematopoietic Stem Cell Transplant Patients With Evidence of Transplant-Associated Gastrointestinal Thrombotic Microangiopathy.对有移植相关胃肠道血栓性微血管病证据的造血干细胞移植患者进行胃肠道活检的完整组织学方法。
Arch Pathol Lab Med. 2017 Nov;141(11):1558-1566. doi: 10.5858/arpa.2016-0599-RA. Epub 2017 Aug 10.
2
Histologic Features of Intestinal Thrombotic Microangiopathy in Pediatric and Young Adult Patients after Hematopoietic Stem Cell Transplantation.造血干细胞移植后儿童及青年患者肠道血栓性微血管病的组织学特征
Biol Blood Marrow Transplant. 2015 Nov;21(11):1994-2001. doi: 10.1016/j.bbmt.2015.06.016. Epub 2015 Jul 4.
3
Intestinal thrombotic microangiopathy: a distinct entity in the spectrum of graft-versus-host disease.肠血栓性微血管病:移植物抗宿主病谱中的一个独特实体。
Int J Hematol. 2019 Nov;110(5):529-532. doi: 10.1007/s12185-019-02750-7. Epub 2019 Oct 4.
4
Stem cell transplantation for induction of remission in medically refractory Crohn's disease.干细胞移植治疗药物难治性克罗恩病诱导缓解。
Cochrane Database Syst Rev. 2022 May 13;5(5):CD013070. doi: 10.1002/14651858.CD013070.pub2.
5
A systematic review of diagnostic, prognostic, and risk blood and urine biomarkers of transplant-associated thrombotic microangiopathy.移植相关性血栓性微血管病的诊断、预后和风险的血液和尿液生物标志物的系统评价。
Front Immunol. 2023 Feb 2;13:1064203. doi: 10.3389/fimmu.2022.1064203. eCollection 2022.
6
Drugs to reduce bleeding and transfusion in major open vascular or endovascular surgery: a systematic review and network meta-analysis.减少大型开放性血管或血管内手术中出血和输血的药物:系统评价和网络荟萃分析。
Cochrane Database Syst Rev. 2023 Feb 17;2(2):CD013649. doi: 10.1002/14651858.CD013649.pub2.
7
Pharmacological interventions for the prevention of bleeding in people undergoing elective hip or knee surgery: a systematic review and network meta-analysis.择期髋关节或膝关节手术患者预防出血的药物干预措施:系统评价和网络荟萃分析。
Cochrane Database Syst Rev. 2024 Jan 16;1(1):CD013295. doi: 10.1002/14651858.CD013295.pub2.
8
Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support.对于接受强化化疗或放疗或两者联合治疗、有或没有造血干细胞支持的血液系统恶性肿瘤患者,采用限制性与宽松性红细胞输血策略的比较。
Cochrane Database Syst Rev. 2017 Jan 27;1(1):CD011305. doi: 10.1002/14651858.CD011305.pub2.
9
Synbiotics, prebiotics and probiotics for solid organ transplant recipients.固体器官移植受者的共生元、益生元和益生菌。
Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD014804. doi: 10.1002/14651858.CD014804.pub2.
10
Continuation versus discontinuation of antiplatelet therapy for bleeding and ischaemic events in adults undergoing non-cardiac surgery.非心脏手术成年患者抗血小板治疗的继续与停用对出血和缺血事件的影响
Cochrane Database Syst Rev. 2018 Jul 18;7(7):CD012584. doi: 10.1002/14651858.CD012584.pub2.

引用本文的文献

1
Small Intestinal Complications of Intestinal Transplant-Associated Microangiopathy Post-stem Cell Transplantation.干细胞移植后肠道移植相关微血管病的小肠并发症
Cureus. 2024 Jul 8;16(7):e64111. doi: 10.7759/cureus.64111. eCollection 2024 Jul.
2
Transplant-associated thrombotic microangiopathy in pediatrics: incidence, risk factors, therapeutic options, and outcome based on data from a single center.儿童移植相关血栓性微血管病:基于单中心数据的发病率、危险因素、治疗选择及预后
Front Oncol. 2024 Jul 10;14:1399696. doi: 10.3389/fonc.2024.1399696. eCollection 2024.
3
Safety and efficacy of narsoplimab in pediatric and adult patients with transplant-associated thrombotic microangiopathy: a real-world experience.
纳武利尤单抗在儿童和成人移植相关血栓性微血管病患者中的安全性和疗效:真实世界经验。
Bone Marrow Transplant. 2024 Aug;59(8):1161-1168. doi: 10.1038/s41409-024-02305-3. Epub 2024 May 21.
4
Neurological involvement in hematopoietic stem cell transplantation-associated thrombotic microangiopathy.造血干细胞移植相关性血栓性微血管病的神经学表现。
Ann Hematol. 2024 Sep;103(9):3303-3313. doi: 10.1007/s00277-024-05798-6. Epub 2024 May 20.
5
Endoscopic manifestation of intestinal transplant-associated microangiopathy after stem cell transplantation.干细胞移植后肠道移植相关微血管病的内镜表现
BMC Gastroenterol. 2024 Apr 22;24(1):140. doi: 10.1186/s12876-024-03221-y.
6
A prospective multi-institutional study of eculizumab to treat high-risk stem cell transplantation-associated TMA.一项前瞻性多机构研究,评估依库珠单抗治疗高危干细胞移植相关性 TMA。
Blood. 2024 Mar 21;143(12):1112-1123. doi: 10.1182/blood.2023022526.
7
Survival analysis of transplant-associated thrombotic microangiopathy under different diagnostic criteria and the efficacy of plasma exchange.不同诊断标准下移植相关性血栓性微血管病的生存分析及血浆置换的疗效。
Ann Transplant. 2023 Jun 20;28:e939890. doi: 10.12659/AOT.939890.
8
Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research.协调移植相关性血栓性微血管病的诊断标准和预后评估定义:欧洲血液和骨髓移植学会、美国移植和细胞治疗学会、亚太血液和骨髓移植学会以及国际血液和骨髓移植研究中心的报告。
Transplant Cell Ther. 2023 Mar;29(3):151-163. doi: 10.1016/j.jtct.2022.11.015. Epub 2022 Nov 25.
9
Pulmonary Manifestations and Vascular Changes in Pediatric Transplantation-Associated Thrombotic Microangiopathy.儿童移植相关性血栓性微血管病的肺部表现和血管变化。
Transplant Cell Ther. 2023 Jan;29(1):45.e1-45.e8. doi: 10.1016/j.jtct.2022.09.026. Epub 2022 Oct 4.
10
Cerebral vascular injury in transplant-associated thrombotic microangiopathy.移植相关性血栓性微血管病中的脑血管损伤。
Blood Adv. 2022 Jul 26;6(14):4310-4319. doi: 10.1182/bloodadvances.2022007453.